Expert Interview
Digging further into therapies in development for Congenital Adrenal Hyperplasia (CAH) including Neurocrine Biosciences gene therapy Crinecerfont
Ticker(s): NBIXDr. Javier Aisenberg, MD
- Pediatric endocrinology specialist in Hackensack, NJ.
- He currently practices at The MOLLY Center for Children with Diabetes and Endocrine Disease and is affiliated with Hackensack Meridian Health Hackensack University Medical Center.
- Dr. Aisenberg graduated from the Universidad De Buenos Aires Facultad De Medicina in 1987.
- Specializes in Diabetes, Endocrinology, Diabetes & Metabolism, Internal Medicine/Pediatrics, Pediatric Endocrinology and Pediatrics.
What is the unmet need, and what patients would stand to benefit from, from additional treatment?
How big you think the market is for Congenital Hyperplasia? How many patients do you think there are in the US, EU, by phenotype, and how many do you think would be interested in pursuing a treatment if it were available?
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
